A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia

Completed

Conditions studied: Critical Limb Ischemia

In brief

Subjects from the AG-CLI-0206 phase 3 study that received AMG0001 will be eligible for the AG-CLI-0206-LTFU study

Key facts

Study ID

NCT02974179

Run by

AnGes USA, Inc.

People needed

9

Starts

2017-02-20

Expected to finish

2020-01-10

Last updated by the study team

2020-03-12

Who can join

Age: 40 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who have been treated with AMG0001 in the AG-CLI-0206 study.
• Subjects who have provided consent for this long term follow-up study either directly or through a legally authorized representative.
• Subjects who have provided a release of information to the sponsor.

You may not qualify if…

• Subjects who were not enrolled in the AGCLI-0206 study.
• Subjects who enrolled in AG-CLI-0206 and who were not treated with AMG0001.
• Subjects who have not provided consent to this long term follow-up study either directly or through a legally authorized representative.
• Subjects who have not provided a release of information for the Sponsor to contact them directly via phone, email and/or mail.

Where it is running

• Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.